Home > Healthcare > Pharmaceuticals > Drug Delivery > Pharmaceutical Drug Delivery Market

Pharmaceutical Drug Delivery Market Share

Report ID: GMI5565
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Pharmaceutical Drug Delivery Market Share

Johnson & Johnson
AstraZeneca plc
AbbVie Inc
Bayer AG
Amgen Inc
Eli Lilly and Company
Sanofi
Merck & Co Inc.
GILEAD SCIENCES, INC.,
Pfizer Inc.

are some of the key players in the global pharmaceutical drug delivery market. Initiatives by the companies like partnerships, collaborations, and new product launches are expected to increase market growth over the years. For instance, in March 2023, Sanofi reduced the cost of their popular insulin Lantus by 78% with a cap of USD 35 in order to make the out-of-pocket drugs more affordable for all patients with commercial insurance.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for pharmaceutical drug delivery was more than USD 1.6 trillion in 2022 and is forecasted to observe more than 7% CAGR from 2023 to 2032.

Infectious diseases segment is predicted to reach more than USD 555 billion by 2032 due to high prevalence of infectious diseases including SARS, swine flu, TB, and others.

North America pharmaceutical drug delivery market share was nearly 49% in 2022 fueled by rising disease prevalence due to factors like high alcohol consumption, smoking, and sedentary lifestyle.

Johnson & Johnson, AstraZeneca plc, AbbVie Inc, Bayer AG, Amgen, Inc., Eli Lilly and Company, Sanofi, Merck & Co. Inc., GILEAD SCIENCES, INC., and Pfizer Inc. are some of the key players in market.